Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by blackascanbeon Aug 25, 2010 1:35pm
349 Views
Post# 17382346

fundamentals

fundamentalsWhat have they been doing since FDA approval? That's like saying, so Capt. Sully what else have you done since you landed your plane on the Hudson River? Getting FDA approval in case you weren't aware is an astounding accomplishment particularly for a company the size of Nuvo. The drug is now being sold ( quite successfully from all accounts to date) by a multibillion dollar multinational corporation who wouldn't waste their time or money selling and then further developing anything that didn't have the potential to add several hundreds of million dollars to their revenue line. Meanwhile these layabouts who took a bankrupt company with no cash, 15 million in debt, and a non approvable letter from the FDA to a company with 33 million in cash, no debt, an FDA approved medication being marketed by one of the most successful medical supply companies in the world. In addition attracting a top notch team of scientists to pursue other drug candidates, not the least of which is WF10 within their award winning subsidary Fquebed. What a bunch of slackers. We should get out of this pig, it doesn't have a future does it?     
Bullboard Posts